Astellas and PeptiDream Enter into Research Collaboration and License Agreement to Discover Novel Targeted Protein Degraders
TOKYO and KANAGAWA – WEBWIRE – Monday, July 24, 2023 Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, ...
Read more
